Opioid prescribing and risks among commercially insured women undergoing pelvic organ prolapse repair-Reference-Cited by-同舟云学术

Opioid prescribing and risks among commercially insured women undergoing pelvic organ prolapse repair

Published:2021-04-19 Issue: Volume: Page:
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Gressler Laura E.¹^ORCID,dosReis Susan¹,Chughtai Bilal²

Affiliation:

1. Department of Pharmaceutical Health Services Research University of Maryland School of Pharmacy Baltimore Maryland USA

2. Department of Urology Weill Cornell Medical College/New York Presbyterian New York New York USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5239

Reference36 articles.

1. Pelvic organ prolapse: review of the aetiology, presentation, diagnosis and management;Machin SE;Menopause Int,2011

2. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction;Haylen BT;Int Urogynecol J,2010

3. Prolapse, pain, and pelvic floor muscle dysfunction;Bradley CS;Am J Obstet Gynecol,2019

4. Lifetime risk of undergoing surgery for pelvic organ prolapse;Smith FJ;Obstet Gynecol,2010

5. Food and Drug Administration.Urogynecologic Surgical Mesh Implants;2019.https://www.fda.gov/medical-devices/implants-and-prosthetics/urogynecologic-surgical-mesh-implants. Accessed April 29 2019.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative Pain Management With Opioid Analgesics in Colpopexy Increases Risk of New Persistent Opioid Usage;Urogynecology;2023-02

2. Subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial;International Urogynecology Journal;2023-01-20